Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1238700

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1238700

Global Preeclampsia Laboratory Testing Market 2023-2027

PUBLISHED:
PAGES: 162 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Technavio has been monitoring the preeclampsia laboratory testing market and is forecast to grow by $785.73 million during 2022-2027, accelerating at a CAGR of 8% during the forecast period. Our report on the preeclampsia laboratory testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by market expansion in emerging economies, increasing incidence of preterm births, and rising number of gynecology clinics.

Technavio's preeclampsia laboratory testing market is segmented as below:

By Product Type

  • Consumables
  • Instruments

By Test

  • Blood test
  • Urine test
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing need for companion diagnostics as one of the prime reasons driving the preeclampsia laboratory testing market growth during the next few years. Also, growing awareness of mother and fetal screening and monitoring procedures and implementation of organic and inorganic strategies by market players will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the preeclampsia laboratory testing market covers the following areas:

  • Preeclampsia laboratory testing market sizing
  • Preeclampsia laboratory testing market forecast
  • Preeclampsia laboratory testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preeclampsia laboratory testing market vendors that include Abbott Laboratories, ACON Laboratories Inc., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidel Corp., Sera Prognostics Inc., Siemens AG, Thermo Fisher Scientific Inc., and Avecon Healthcare Pvt. Ltd. Also, the preeclampsia laboratory testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75037

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Test
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global preeclampsia laboratory testing market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global preeclampsia laboratory testing market 2017 - 2021 ($ million)
  • 4.2 Product Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Product Type Segment 2017 - 2021 ($ million)
  • 4.3 Test Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Test Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Product Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Product Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Product Type
  • Exhibit 32: Chart on Comparison by Product Type
  • Exhibit 33: Data Table on Comparison by Product Type
  • 6.3 Consumables - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • 6.4 Instruments - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Product Type
  • Exhibit 42: Market opportunity by Product Type ($ million)
  • Exhibit 43: Data Table on Market opportunity by Product Type ($ million)

7 Market Segmentation by Test

  • 7.1 Market segments
  • Exhibit 44: Chart on Test - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Test - Market share 2022-2027 (%)
  • 7.2 Comparison by Test
  • Exhibit 46: Chart on Comparison by Test
  • Exhibit 47: Data Table on Comparison by Test
  • 7.3 Blood test - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Blood test - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Blood test - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Blood test - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Blood test - Year-over-year growth 2022-2027 (%)
  • 7.4 Urine test - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Urine test - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Urine test - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Urine test - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Urine test - Year-over-year growth 2022-2027 (%)
  • 7.5 Others - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Test
  • Exhibit 60: Market opportunity by Test ($ million)
  • Exhibit 61: Data Table on Market opportunity by Test ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
  • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 UK - Market size and forecast 2022-2027
  • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.11 India - Market size and forecast 2022-2027
  • Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 103: Market opportunity by geography ($ million)
  • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 111: Abbott Laboratories - Overview
  • Exhibit 112: Abbott Laboratories - Business segments
  • Exhibit 113: Abbott Laboratories - Key news
  • Exhibit 114: Abbott Laboratories - Key offerings
  • Exhibit 115: Abbott Laboratories - Segment focus
  • 12.4 ACON Laboratories Inc.
  • Exhibit 116: ACON Laboratories Inc. - Overview
  • Exhibit 117: ACON Laboratories Inc. - Product / Service
  • Exhibit 118: ACON Laboratories Inc. - Key offerings
  • 12.5 Bio Rad Laboratories Inc.
  • Exhibit 119: Bio Rad Laboratories Inc. - Overview
  • Exhibit 120: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 121: Bio Rad Laboratories Inc. - Key news
  • Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 123: Bio Rad Laboratories Inc. - Segment focus
  • 12.6 BioCheck Inc.
  • Exhibit 124: BioCheck Inc. - Overview
  • Exhibit 125: BioCheck Inc. - Product / Service
  • Exhibit 126: BioCheck Inc. - Key offerings
  • 12.7 bioMerieux SA
  • Exhibit 127: bioMerieux SA - Overview
  • Exhibit 128: bioMerieux SA - Product / Service
  • Exhibit 129: bioMerieux SA - Key offerings
  • 12.8 Biora Therapeutics Inc.
  • Exhibit 130: Biora Therapeutics Inc. - Overview
  • Exhibit 131: Biora Therapeutics Inc. - Product / Service
  • Exhibit 132: Biora Therapeutics Inc. - Key offerings
  • 12.9 Cardinal Health Inc.
  • Exhibit 133: Cardinal Health Inc. - Overview
  • Exhibit 134: Cardinal Health Inc. - Business segments
  • Exhibit 135: Cardinal Health Inc. - Key news
  • Exhibit 136: Cardinal Health Inc. - Key offerings
  • Exhibit 137: Cardinal Health Inc. - Segment focus
  • 12.10 Diabetomics Inc.
  • Exhibit 138: Diabetomics Inc. - Overview
  • Exhibit 139: Diabetomics Inc. - Product / Service
  • Exhibit 140: Diabetomics Inc. - Key offerings
  • 12.11 F. Hoffmann La Roche Ltd.
  • Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 MedGyn Products Inc.
  • Exhibit 146: MedGyn Products Inc. - Overview
  • Exhibit 147: MedGyn Products Inc. - Product / Service
  • Exhibit 148: MedGyn Products Inc. - Key offerings
  • 12.13 Metabolomic Diagnostics
  • Exhibit 149: Metabolomic Diagnostics - Overview
  • Exhibit 150: Metabolomic Diagnostics - Product / Service
  • Exhibit 151: Metabolomic Diagnostics - Key offerings
  • 12.14 Perkin Elmer Inc.
  • Exhibit 152: Perkin Elmer Inc. - Overview
  • Exhibit 153: Perkin Elmer Inc. - Business segments
  • Exhibit 154: Perkin Elmer Inc. - Key news
  • Exhibit 155: Perkin Elmer Inc. - Key offerings
  • Exhibit 156: Perkin Elmer Inc. - Segment focus
  • 12.15 Sera Prognostics Inc.
  • Exhibit 157: Sera Prognostics Inc. - Overview
  • Exhibit 158: Sera Prognostics Inc. - Product / Service
  • Exhibit 159: Sera Prognostics Inc. - Key offerings
  • 12.16 Siemens AG
  • Exhibit 160: Siemens AG - Overview
  • Exhibit 161: Siemens AG - Business segments
  • Exhibit 162: Siemens AG - Key news
  • Exhibit 163: Siemens AG - Key offerings
  • Exhibit 164: Siemens AG - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 165: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 167: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 170: Inclusions checklist
  • Exhibit 171: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 172: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 173: Research methodology
  • Exhibit 174: Validation techniques employed for market sizing
  • Exhibit 175: Information sources
  • 13.5 List of abbreviations
  • Exhibit 176: List of abbreviations
Product Code: IRTNTR75037

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Test
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global preeclampsia laboratory testing market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Product Type Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Test Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Product Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Product Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Product Type
  • Exhibits33: Data Table on Comparison by Product Type
  • Exhibits34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Product Type ($ million)
  • Exhibits43: Data Table on Market opportunity by Product Type ($ million)
  • Exhibits44: Chart on Test - Market share 2022-2027 (%)
  • Exhibits45: Data Table on Test - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by Test
  • Exhibits47: Data Table on Comparison by Test
  • Exhibits48: Chart on Blood test - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Data Table on Blood test - Market size and forecast 2022-2027 ($ million)
  • Exhibits50: Chart on Blood test - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on Blood test - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Urine test - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Urine test - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Urine test - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Urine test - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Market opportunity by Test ($ million)
  • Exhibits61: Data Table on Market opportunity by Test ($ million)
  • Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits63: Chart on Market share by geography 2022-2027 (%)
  • Exhibits64: Data Table on Market share by geography 2022-2027 (%)
  • Exhibits65: Chart on Geographic comparison
  • Exhibits66: Data Table on Geographic comparison
  • Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on India - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Market opportunity by geography ($ million)
  • Exhibits104: Data Tables on Market opportunity by geography ($ million)
  • Exhibits105: Impact of drivers and challenges in 2022 and 2027
  • Exhibits106: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits107: Overview on factors of disruption
  • Exhibits108: Impact of key risks on business
  • Exhibits109: Vendors covered
  • Exhibits110: Matrix on vendor position and classification
  • Exhibits111: Abbott Laboratories - Overview
  • Exhibits112: Abbott Laboratories - Business segments
  • Exhibits113: Abbott Laboratories - Key news
  • Exhibits114: Abbott Laboratories - Key offerings
  • Exhibits115: Abbott Laboratories - Segment focus
  • Exhibits116: ACON Laboratories Inc. - Overview
  • Exhibits117: ACON Laboratories Inc. - Product / Service
  • Exhibits118: ACON Laboratories Inc. - Key offerings
  • Exhibits119: Bio Rad Laboratories Inc. - Overview
  • Exhibits120: Bio Rad Laboratories Inc. - Business segments
  • Exhibits121: Bio Rad Laboratories Inc. - Key news
  • Exhibits122: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits123: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits124: BioCheck Inc. - Overview
  • Exhibits125: BioCheck Inc. - Product / Service
  • Exhibits126: BioCheck Inc. - Key offerings
  • Exhibits127: bioMerieux SA - Overview
  • Exhibits128: bioMerieux SA - Product / Service
  • Exhibits129: bioMerieux SA - Key offerings
  • Exhibits130: Biora Therapeutics Inc. - Overview
  • Exhibits131: Biora Therapeutics Inc. - Product / Service
  • Exhibits132: Biora Therapeutics Inc. - Key offerings
  • Exhibits133: Cardinal Health Inc. - Overview
  • Exhibits134: Cardinal Health Inc. - Business segments
  • Exhibits135: Cardinal Health Inc. - Key news
  • Exhibits136: Cardinal Health Inc. - Key offerings
  • Exhibits137: Cardinal Health Inc. - Segment focus
  • Exhibits138: Diabetomics Inc. - Overview
  • Exhibits139: Diabetomics Inc. - Product / Service
  • Exhibits140: Diabetomics Inc. - Key offerings
  • Exhibits141: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits143: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits146: MedGyn Products Inc. - Overview
  • Exhibits147: MedGyn Products Inc. - Product / Service
  • Exhibits148: MedGyn Products Inc. - Key offerings
  • Exhibits149: Metabolomic Diagnostics - Overview
  • Exhibits150: Metabolomic Diagnostics - Product / Service
  • Exhibits151: Metabolomic Diagnostics - Key offerings
  • Exhibits152: Perkin Elmer Inc. - Overview
  • Exhibits153: Perkin Elmer Inc. - Business segments
  • Exhibits154: Perkin Elmer Inc. - Key news
  • Exhibits155: Perkin Elmer Inc. - Key offerings
  • Exhibits156: Perkin Elmer Inc. - Segment focus
  • Exhibits157: Sera Prognostics Inc. - Overview
  • Exhibits158: Sera Prognostics Inc. - Product / Service
  • Exhibits159: Sera Prognostics Inc. - Key offerings
  • Exhibits160: Siemens AG - Overview
  • Exhibits161: Siemens AG - Business segments
  • Exhibits162: Siemens AG - Key news
  • Exhibits163: Siemens AG - Key offerings
  • Exhibits164: Siemens AG - Segment focus
  • Exhibits165: Thermo Fisher Scientific Inc. - Overview
  • Exhibits166: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits167: Thermo Fisher Scientific Inc. - Key news
  • Exhibits168: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits169: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits170: Inclusions checklist
  • Exhibits171: Exclusions checklist
  • Exhibits172: Currency conversion rates for US$
  • Exhibits173: Research methodology
  • Exhibits174: Validation techniques employed for market sizing
  • Exhibits175: Information sources
  • Exhibits176: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!